AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29615077
Drug: GC chemotherapy
RxNorm normalized name: GCS-100
DrugBank: GCS-100 (DB17566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GC chemotherapy (cisplatin 70 mg/m2, IV infusion, day 8; gemcitabine 1000 mg/m2, IV infusion, days 8 and 15)
Trial: 22686495
Drug: Intranasal oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal oxycodone (0, 14 & 28 mg)
Trial: 20556471
Drug: 3‐monthly laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3‐monthly laser treatments with a StarLux 1,540‐nm fractional handpiece
Trial: 18793361
Drug: Chemo-mechanical root
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemo-mechanical root canal preparation
Trial: 12766099
Drug: Oolong tea
RxNorm normalized name: oolong tea leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oolong tea (1,500 ml) for 30 days
Trial: 8930172
Drug: Sodium dichloroacetate
RxNorm normalized name: sodium dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium dichloroacetate (DCA) 30 mg/kg
Trial: 8930172
Drug: Sodium dichloroacetate
RxNorm normalized name: sodium dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium dichloroacetate (DCA) 100 mg/kg
Trial: 8930172
Drug: Sodium dichloroacetate
RxNorm normalized name: sodium dichloroacetate
DrugBank: Sodium dichloroacetate (DB16929)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium dichloroacetate (DCA) 15-50 mg/kg (second infusions)
Trial: 6423317
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate aerosol (1 mg/actuation)
Trial: 6423317
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate via Spinhaler (20 mg)
Trial: 30282077
Drug: Sodium hyaluronate
RxNorm normalized name: sodium hyaluronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium hyaluronate (SH) treatment
Trial: 29590544
Drug: 3 months
RxNorm normalized name: TABLET, DOSE PACK, 3 MONTHS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 months of therapy (combined regimens)
Trial: 29590544
Drug: 6 months
RxNorm normalized name: leuprolide 45 mg/6 months intramuscular kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 months of therapy (combined regimens)
Trial: 1449019
Drug: Urso plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urso plus colchicine (1 mg/day)
Trial: 1449019
Drug: Urso alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urso alone (10-12 mg/kg) for 12 months
Trial: 16326671
Drug: Landiolol (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (0.25 to 0.5 mg.kg(‐1))
Trial: 16326671
Drug: Esmolol (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (1.0 mg.kg(‐1))
Trial: 16326671
Drug: Landiolol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Landiolol (0.5 mg.kg(‐1))
Trial: 12432320
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (CON) with tracheostomy performed on PBD 14 if necessary
Trial: 10521736
Drug: Oral nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral nifedipine (20 mg every 4‐6 hours)
Trial: 8890875
Drug: Pharmaceutical interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical interventions
Trial: 1683333
Drug: Zotepine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zotepine (3 x 75 mg)
Trial: 1683333
Drug: Haloperidol (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (3 x 4 mg)
Trial: 27794080
Drug: Oxygen at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen at 2 L/min
Trial: 27794080
Drug: Air at
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air at 2 L/min
Trial: 15827910
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) and medication therapy (MT) for the first 6 weeks, followed by MT only for the second 6 weeks.
Trial: 15827910
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (PT) and medication therapy (MT) for the second 6 weeks after receiving only MT for the first 6 weeks.
Trial: 12350390
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) as adjunctive therapy, initiated at 0.5-1 mg/kg, titrated to a maximum of 12 mg/kg over a mean treatment period of 15.8 months (range 3-98 months).
Trial: 12350390
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) as adjunctive therapy.
Trial: 8952810
Drug: Indapamide 1.5
RxNorm normalized name: indapamide 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 1.5 mg sustained-release form
Trial: 8952810
Drug: Indapamide 2.5
RxNorm normalized name: indapamide 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indapamide 2.5 mg immediate-release form
Trial: 1935254
Drug: 2 percent
RxNorm normalized name: ALCOHOL 62 mL in 100 mL TOPICAL GEL [The Keeps ETHANOL 62 percent]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 percent topical minoxidil
Trial: 25025854
Drug: Biphasic calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biphasic calcium sulfate (CS) in combination with gamma‐radiated human mineralized allograft
Trial: 18343262
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (3-12 mg)
Trial: 18343262
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (3, 6, 9, 12, 15 mg/d)
Trial: 12734745
Drug: Amlodipine suspension
RxNorm normalized name: amlodipine Oral Suspension
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine suspension
Trial: 12734745
Drug: Amlodipine tablets
RxNorm normalized name: Levamlodipine Tablets
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine tablets
Trial: 8739863
Drug: Astemizole-D (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Astemizole-D (10 mg astemizole and 240 mg pseudoephedrine)
Trial: 8739863
Drug: Brompheniramine-D (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brompheniramine-D (12 mg brompheniramine and 50 mg phenylpropanolamine)
Trial: 1911497
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg epidural morphine and 100 micrograms fentanyl
Trial: 25609940
Drug: Glycopyrronium 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrronium 50 μg once daily
Trial: 21162825
Drug: Fasting capillary
RxNorm normalized name: Artemisia capillaris leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting capillary blood glucose cut-off value of 6.0 mmol/L for undiagnosed diabetes mellitus
Trial: 21162825
Drug: Fasting capillary
RxNorm normalized name: Artemisia capillaris leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting capillary blood glucose cut-off value of 5.7 mmol/L for impaired fasting glucose (IFG)
Trial: 21162825
Drug: Fasting capillary
RxNorm normalized name: Artemisia capillaris leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fasting capillary blood glucose cut-off value of 5.7 mmol/L for impaired glucose tolerance (IGT)
Trial: 17764477
Drug: Conventional cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cigarettes (FTC tar 11 mg; CC1)
Trial: 17764477
Drug: Conventional cigarettes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cigarettes (FTC tar 6 mg; CC2)
Trial: 17764477
Drug: Cigarette switch
RxNorm normalized name: Witch Hazel
DrugBank: Witch hazel (DB11111)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cigarette switch (FTC tar 1 mg; CC3)
Trial: 15564721
Drug: Rituximab (anti-CD20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (anti-CD20 antibody), administered in up to 4 treatment cycles, possibly in combination with corticosteroid, cyclophosphamide, and/or methotrexate.
Trial: 15564721
Drug: Rituximab (anti-CD20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (anti-CD20 antibody)
Trial: 11953726
Drug: Cephalexin (80-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin (80-100 mg/kg/day)
Trial: 9876550
Drug: Metoprolol (generic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (generic preparation)
Trial: 31678947
Drug: Exercise 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise 150 min/week + Liraglutide 3.0 mg/day
Trial: 28143414
Drug: Toothbrushing plus
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Toothbrushing plus 0.12% chlorhexidine gel
Trial: 28143414
Drug: Chlorhexidine solution
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 99.0 g in 1 L TOPICAL SOLUTION [CHLORHEXIDINE Solution]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine solution 0.12% without toothbrushing
Trial: 18172769
Drug: Drug Court
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug Court with usual community‐based treatment (DC)
Trial: 18172769
Drug: DC with
RxNorm normalized name: ADC with Fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DC with Multisystemic Therapy (DC/MST)
Trial: 18172769
Drug: Family Court
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family Court with usual community‐based treatment (FC)
Trial: 17926489
Drug: Complex treatment
RxNorm normalized name: hesperidin complex
DrugBank: Citrus bioflavonoids (DB14586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complex treatment with monocinque and melatonin
Trial: 17926489
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with monocinque
Trial: 9684909
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (120 mg ZnSO4 after each dialysis session)
Trial: 2670447
Drug: 5000 IU
RxNorm normalized name: D 5000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5000 IU of heparin (subcutaneously, twice daily) for 14 to 21 days
Trial: 2670447
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without anticoagulant prophylaxis
Trial: 1158003
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution infiltration
Trial: 3111166
Drug: 5% glucose
RxNorm normalized name: Dextrose/Water 5% Oral Solution [ENFAMIL 5% GLUCOSE IN WATER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% glucose intravenous infusion
Trial: 21219504
Drug: Oral swab
RxNorm normalized name: Moi-Stir, oral swab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral swab test
Trial: 7854376
Drug: Clotrimazole troches
RxNorm normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clotrimazole troches (10 mg taken five times daily)
Trial: 1941832
Drug: Auranofin (AF)
RxNorm normalized name: Auranofin
DrugBank: Auranofin (DB00995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Auranofin (AF) at a dosage of 0.15‐0.2 mg/kg/day (9 mg/day maximum)
Trial: 19736051
Drug: Polyethylene glycol
RxNorm normalized name: Polyethylene Glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polyethylene glycol and simethicone solution (2l) 16h before VCE
Trial: 12090863
Drug: 0.625 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/d of conjugated estrogens plus 2.5 mg of medroxyprogesterone acetate
Trial: 11339515
Drug: Intramuscular meloxicam
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular meloxicam (15 mg)
Trial: 11339515
Drug: Oral meloxicam
RxNorm normalized name: Meloxicam
DrugBank: Meloxicam (DB00814)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral meloxicam (15 mg)
Trial: 2040038
Drug: High-dose methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylprednisolone (120 mg i.v. repeated after 4 hours) + metoclopramide (0.5 mg/kg i.v. bolus over 30 min + 1 mg/kg continuous infusion over 24 h) + alprazolam (0.5 mg p.o.)
Trial: 2040038
Drug: Conventional antiemetic
RxNorm normalized name: metoclopramide
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional antiemetic regimen (metoclopramide + alprazolam) without high-dose methylprednisolone
Trial: 31964449
Drug: AMPH ER
RxNorm normalized name: AMPH-b
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AMPH ER TAB 20 mg swallowed (fasted)
Trial: 31964449
Drug: AMPH ER
RxNorm normalized name: AMPH-b
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AMPH ER TAB 20 mg chewed (fed/fasted)
Trial: 24915175
Drug: Saffron (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron (300 mg/d)
Trial: 24915175
Drug: Indomethacin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (75 mg, 25 mg thrice a day)
Trial: 23809501
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist initiation on cycle day 2
Trial: 23809501
Drug: GnRH antagonist
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: GnRH antagonist initiation on cycle day 6 (control)
Trial: 19898206
Drug: Standard tacrolimus
RxNorm normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard tacrolimus with mycophenolate mofetil and steroids until day 91 (Tac‐s)
Trial: 18085138
Drug: Integration treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integration treatment group (AMIE methods: acupuncture, massage, injection, and animal exercise therapies)
Trial: 18085138
Drug: Rehabilitation group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation group (Bobath training therapy)
Trial: 14967451
Drug: EGFR inhibitors
RxNorm normalized name: Egfr t790m inhibitor pf-06747775
DrugBank: Mavelertinib (DB16228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR inhibitors (monoclonal antibodies and small molecular weight compounds)
Trial: 14967451
Drug: Combination therapies
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapies with EGFR inhibitors
Trial: 12588463
Drug: Glucagon (4.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucagon (4.8 microg kg(‐1) bolus followed by 9.6 microg kg(‐1) h(‐1) infusion)
Trial: 10948696
Drug: Desmopressin (0.396
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin (0.396 microgram administered intravenously as a bolus injection)
Trial: 29185878
Drug: Problem-Solving Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Problem-Solving Therapy (PST) for 6 weeks
Trial: 27004462
Drug: Nutraceutical combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutraceutical combination (NC)
Trial: 30471555
Drug: No active
RxNorm normalized name: Aveeno Active Naturals
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No active treatment (noNC)
Trial: 20439345
Drug: Liposomal cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal cisplatin (200 mg/m²) and paclitaxel (135 mg/m²)
Trial: 20439345
Drug: Cisplatin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (75 mg/m²) and paclitaxel (135 mg/m²)
Trial: 23932956
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy by mothers
Trial: 11893434
Drug: Massage therapy
RxNorm normalized name: CAMPHOR (SYNTHETIC) 30 g in 1 mL / MENTHOL 40 g in 1 mL TOPICAL OIL [CBDMEDIC MASSAGE THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Massage therapy by trained professionals
Trial: 9689902
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D administration in addition to Rifampicin, Isoniazid and Streptomycin (Group B)
Trial: 4214889
Drug: Routine postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine postoperative irradiation therapy
Trial: 12730150
Drug: nCPAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nCPAP treatment
Trial: 17296461
Drug: Tramadol 37.5-mg/acetaminophen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 37.5-mg/acetaminophen 325-mg combination tablets (tramadol/APAP)
Trial: 14521597
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg alternate daily
Trial: 14521597
Drug: Tamoxifen 10
RxNorm normalized name: tamoxifen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 10 mg day-1
Trial: 14521597
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg day-1
Trial: 2442543
Drug: Enalapril, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 10 mg b.i.d. on a low sodium diet (50 mmol sodium/24 h)
Trial: 2442543
Drug: Enalapril, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 10 mg b.i.d. on a liberal sodium diet (200 mmol sodium/24 h)
Trial: 2442543
Drug: Enalapril, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 10 mg b.i.d. on both diets
Trial: 31420190
Drug: PCOS pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: PCOS pharmaceutical care service (verbal and written educational materials focusing on diet and exercise)
Trial: 24087999
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (60 mg/day for 8 weeks)
Trial: 16111790
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of live attenuated oral monovalent G1 human rotavirus vaccine
Trial: 16111790
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of live attenuated oral monovalent G1 human rotavirus vaccine
Trial: 16111790
Drug: Routine childhood
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine childhood vaccines
Trial: 16111790
Drug: Both dosages
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosages of HRV vaccine
Trial: 3577278
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g Mezlocillin (Baypen) i.v.
Trial: 23873670
Drug: ONO‐5334 50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 50 mg twice daily
Trial: 23873670
Drug: ONO‐5334 100 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 100 mg once daily
Trial: 23873670
Drug: ONO‐5334 300 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO‐5334 300 mg once daily
Trial: 23873670
Drug: Alendronate 70 mg
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate 70 mg once weekly
Trial: 15968885
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of S-3304 (10 - 800 mg)
Trial: 15968885
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose of S-3304 (200 mg, 400 mg, 800 mg b.i.d.)
Trial: 15968885
Drug: Multiple dose
RxNorm normalized name: Rebetron, multiple dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple dose of S-3304 (800 mg b.i.d.)
Trial: 15968885
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of S-3304 (800 mg)
Trial: 15968885
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of S-3304 (high-fat diet effect)
Trial: 15968885
Drug: Multiple doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple doses of S-3304
Trial: 15968885
Drug: S-3304 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-3304 (800 mg b.i.d.)
Trial: 14629247
Drug: Ergotamine tartrate
RxNorm normalized name: Ergotamine Tartrate
DrugBank: Ergotamine (DB00696)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ergotamine tartrate 2 mg
Trial: 11307227
Drug: Oral Health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Health Status Questionnaire (OHSQ)
Trial: 8885732
Drug: Terbutaline 5
RxNorm normalized name: terbutaline 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline 5 mg orally every 4 hours